德国NMDAR脑炎患者的结构性脑改变与临床结局:横断面研究
该横断面研究纳入70例急性期后NMDAR脑炎患者并按1:1匹配健康对照,发现患者脑形态复杂性降低(海马及额-扣带-颞簇),且持续精神症状和记忆障碍者结构改变更显著,精神症状从精神病性为主转为情感性为主。
要点
- 急性期后NMDAR脑炎患者67%仍有残留症状,以记忆障碍(61%)和精神症状(36%)最常见。
- 患者脑形态复杂性降低涉及双侧海马及额-扣带-颞灰白质簇,持续症状者改变更强。
- 精神症状表型从急性期精神病性为主转为急性期后情感性为主,提示需 structured 急性期后照护。
核心结论
- 急性期后NMDAR脑炎存在系统性脑形态改变,与持续精神症状和记忆障碍相关。
- 分形维度可作为长期结局的潜在影像标志物。
- 精神症状表型转变和记忆障碍持续提示需结构化急性期后照护。
研究设计与样本
- 横断面研究,纳入德国Charité-Universitätsmedizin Berlin转诊的急性期后NMDAR脑炎患者70例。
- 按性别和年龄1:1匹配健康对照70例,使用逻辑回归倾向评分和最近邻匹配。
- 数据收集于2011年7月18日至2021年3月17日,评估工具包括mRS、CASE、精神表型分型和神经心理测试。
主要发现
- 残留症状最常见为记忆障碍43例(61%)和精神症状25例(36%)。
关键数值与推荐
- 精神症状从急性期精神病性为主转变为急性期后情感性为主。
临床怎么用
- 对NMDAR脑炎患者急性期后应常规评估精神症状和记忆功能。
- 分形维度分析可作为评估长期结局的潜在影像标志物。
- 需建立结构化急性期后照护以处理长期情感和认知障碍。
局限性
- 横断面设计无法推断因果关系。
- 样本来自单一转诊中心,可能存在选择偏倚。
- ethnicity数据不可用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Many patients with N-methyl-D-aspartate receptor (NMDAR) encephalitis show persistent neurological or psychiatric symptoms, despite immunotherapy. The neuroanatomical basis of these symptoms remains uncertain. Morphological complexity analysis with fractal dimensionality has emerged as a sensitive neuroimaging method in related conditions, but remains unexplored in autoimmune encephalitis. We aimed to characterise morphological brain complexity, symptom trajectories from peak illness to the post-acute stage, and the relationship between structural brain changes and post-acute outcomes in patients with NMDAR encephalitis. METHODS: In this cross-sectional study, we included patients with post-acute NMDAR encephalitis referred to Charité-Universitätsmedizin Berlin, Germany. Patients were matched (1:1) to healthy control participants for sex and age by use of logistic regression propensity scores and nearest-neighbour matching. Data were collected between July 18, 2011, and March 17, 2021. Patient outcomes were assessed with the modified Rankin Scale (mRS), Clinical Assessment Scale for Autoimmune Encephalitis (CASE), psychiatric phenotyping, and neuropsychological testing. Morphological brain complexity was quantified from T1-weighted structural MRI. Normative modelling was used to evaluate the relationship between structural brain changes and post-acute outcomes. Self-reports on post-acute symptoms by individuals with lived experience informed the study design. FINDINGS: We included 70 patients (60 [86%] female and ten [14%] male; mean age 28·1 years [SD 10·2; range 15·0-67·0]) and 70 age-matched and sex-matched healthy control participants (60 [86%] female and ten [14%] male; 29·0 [9·3; 16·0-65·2]; ethnicity data unavailable). Study visits occurred at a median of 22·2 months from disease onset (IQR 8·5-42·5). Patients were severely affected at peak illness, but showed significant clinical improvement in both mRS (median 5 vs 1, Z -7·2, p<0·0001) and CASE (median 11 vs 1, Z -7·2, p<0·0001) in the post-acute stage. Nevertheless, 47 (67%) patients continued to show residual CASE symptoms, most commonly memory dysfunction (43 [61%]) and psychiatric symptoms (25 [36%]). In patients with persistent symptoms, psychiatric manifestations shifted from a psychosis-dominant phenotype at peak illness to an affective-dominant phenotype in the post-acute stage. Brain imaging showed a characteristic pattern of reduced morphological complexity, including the hippocampus bilaterally and a fronto-cingulo-temporal cluster in grey and white matter. Normative modelling revealed that patients with persistent symptoms showed stronger alterations of brain morphology than those without (psychiatric symptoms: t -2·65, p=0·0100; memory dysfunction: t -3·98, p=0·0002; both vs no symptoms t -5·46, p<0·0001). Similarly, stronger morphological alterations were associated with lower visuospatial and verbal memory performance (all pFDR<0·015). INTERPRETATION: Post-acute NMDAR encephalitis is characterised by systematic alterations of brain morphology. These changes are associated with persistent psychiatric symptoms and memory dysfunction after immunotherapy, highlighting fractal dimensionality as a promising new imaging marker of long-term outcomes. The phenotypic shift in psychiatric symptoms and the persistence of memory dysfunction highlight the importance of structured post-acute care to address long-term affective and cognitive morbidity in patients with NMDAR encephalitis. FUNDING: German Research Foundation and German Ministry of Education and Research.
引用
- Krohn S, Cammà G, Zhao W, et al. Structural brain changes and clinical outcomes of patients with NMDA receptor encephalitis in Germany: a cross-sectional study. Lancet Psychiatry. 2026. PMID: 42586080. doi:10.1016/S2215-0366(26)00191-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。